Recent evidence supports the view that bacterial vaginosis presents as a polymicrobial biofilm infection. This has far-reaching implications for the pathogenesis, epidemiology, diagnosis and treatment of bacterial vaginosis.
INTRODUCTION
Contrary to our traditional view of infectious diseases resulting from colonization with a single microbial species, it has recently been acknowledged -mostly because of the advent of molecular bacterial identification techniques -that microbes actually rarely exist as single-species planktonic forms, but rather the majority of microbes are found thriving in complex polymicrobial biofilm communities [1 && ]. This has recently been shown to be also the case for bacterial vaginosis, a pervasive polymicrobial infestation of the vagina that affects millions of women worldwide. Swidsinski et al.
[2 && ] documented through fluorescence in-situhybridization (FISH) analysis of vaginal biopsies obtained from women with and without bacterial vaginosis that a characteristic dense biofilm in confluent or patchy layers covered at least 50% of the vaginal epithelial surface in 90% of biopsies obtained from women with bacterial vaginosis as compared to 10% of women without bacterial vaginosis. Vaginal biopsies in women without bacterial vaginosis showed mostly loosely dispersed lactic acid bacteria, including Lactobacillus, Streptococcus, and Enterococcus bacteria. The biofilm was found to consist primarily of Gardnerella vaginalis, whilst Atopobium vaginae was present in 80% of the cases and made up 40% of the biofilm mass. Other bacteria were found more inconsistently, including bacteria belonging to the Bacteroides, Corynebacterium, Lactobacillus, Veillonella, Ruminococcus and Streptococcus genera [2
IMPLICATIONS FOR THE EPIDEMIOLOGY OF BACTERIAL VAGINOSIS
With only a few risk factors having been identified for bacterial vaginosis, study of bacterial vaginosis epidemiology has traditionally largely focussed on the occurrence of bacterial vaginosis in relation to sexual behaviour. The literature on the epidemiology of G. vaginalis and bacterial vaginosis in relation to sexual behaviour has recently comprehensively been reviewed [3] . Clearly, the epidemiology of bacterial vaginosis is intricate, and from the latter review data emerged that support male-to-female transmission as well as female-to-male transmission of bacterial vaginosis.
Building further on the discovery of the bacterial vaginosis biofilm [2 && ], Swidsinski et al. [4 && ] refined the picture of bacterial vaginosis transmissibility to a significant extent. The authors first described that the presence of G. vaginalis can also reliably be assessed through FISH analysis of desquamated epithelial cells in urine sediments in both women and men, as further discussed below. By doing so, it was observed that G. vaginalis presented in two distinct ways, that is, desquamated cells in urine showed either 'dispersed' Gardnerella, consisting of loosely dispersed Gardnerella cells indicative of planktonic growth, or 'cohesive' Gardnerella, consisting of clustered Gardnerella cells adhesive to the epithelium, the latter indicative of the presence of Gardnerella in a biofilm mode of growth [4 && ]. The authors then enrolled, amongst others, 20 women with symptomatic bacterial vaginosis and 10 of their partners, and 72 consecutive married pregnant women and their 72 partners [4 && ]. It was shown that the 20 women with symptomatic bacterial vaginosis consistently presented with cohesive Gardnerella as did the 10 partners investigated. Amongst the 72 married pregnant women and their 72 partners, dispersed Gardnerella was found in 14% and cohesive Gardnerella in 17% of the women. Again, cohesive Gardnerella was consistently found amongst the partners of the women with cohesive Gardnerella for whom the samples were analysable. No such concordance was observed for dispersed Gardnerella. Hence, the previously known strong concordance of G. vaginalis carriage by both partners when a woman has bacterial vaginosis [3] was herewith [4 && ] confirmed, but further refined by the almost absolute concordance of cohesive Gardnerella carriage. From these observations, it may be inferred that the biofilm mode of growth represents the infectious or transmissible mode of Gardnerella and bacterial vaginosis, whereas the mere presence of dispersed Gardnerella seems at present of less clinical significance. Of note in this respect is that bacterial density within the biofilm mass is within the order of 10 10-11 cells per gram as compared to 10 6-8 cells per gram for planktonic bacteria in vaginal fluid [5] .
As mentioned above, the aforementioned approach also allows detection of cohesive Gardnerella, consisting of voided epithelial cells covered with the polymicrobial Gardnerella biofilm, in men. This is of particular interest for epidemiologic bacterial vaginosis research. For instance, Swidsinski et al. [6] documented the presence of cohesive Gardnerella covering epithelial cells in randomly selected cryopreserved semen samples, reflecting a possible mode of infection. Of note is that voided epithelial cells are only recovered in sufficient amounts in men if the prepuce rests over the glans penis when voiding and not when the prepuce is pulled back, which also seem to suggest that the voided cells are preputial pocket-lining cells [4 && ]. It is not entirely clear from the recent genomic studies whether the dispersed and cohesive Gardnerella modes of growth also represent different Gardnerella strains. Yeoman et al. [7] revealed that different Gardnerella strains show substantial differences in metabolic and virulence potential; however, they also found that all strains investigated had exopolysaccharide biosynthetic genes that are involved in encoding biofilm formation. Harwich et al. [8 && ] however conducted a genomic analysis of two Gardnerella strains, isolated from a woman with bacterial vaginosis and a woman without bacterial vaginosis, respectively. They found that the bacterial vaginosis-associated strain encoded a different variant of a biofilm-associated protein gene and
KEY POINTS
G. vaginalis can be present in the vagina in a planktonic or in a biofilm mode of growth.
The presence of planktonic (dispersed) or biofilmassociated (cohesive) G. vaginalis can be reliably shown in urine sediments in both women and men.
There is an absolute concordance in the carriage of biofilm-associated (cohesive) ]. This might explain why G. vaginalis and A. vaginae are such strong indicators of bacterial vaginosis [10] , whilst other bacteria, presumably secondary colonizers, are found in a less consistent manner in association with bacterial vaginosis.
IMPLICATIONS FOR THE DIAGNOSIS OF BACTERIAL VAGINOSIS
Current gold-standard diagnosis of bacterial vaginosis relies on categorizing Gram-stained vaginal smears under oil immersion microscopy through Nugent scoring [11] or modifications thereof like Hay-Ison scoring [12] . Overall, the Nugent scoring system has a high degree of accuracy, high intracentre and intercentre reliability, as well as high intraobserver and interobserver reproducibility [13] . Swidsinski et al. 
IMPLICATIONS FOR THE TREATMENT OF BACTERIAL VAGINOSIS
Treatment of bacterial vaginosis has been a longstanding challenge. Standard regimens with metronidazole or clindamycin as recommended by the U.S. Centers for Disease Control and Prevention (CDC) are associated with fairly good short-term cure rates, but, however, also with high recurrence rates in the long run [13] . Hence, it has been questioned whether such high recurrence rates reflect antibiotic resistance, recurrence or reinfection [14] .
Swidsinski et al. [15 && ] then conducted a longitudinal study in which 18 patients were treated with a standard oral regime of metronidazole and followed for 5 weeks. Through repeated vaginal biopsy and FISH imaging of the vaginal biofilm, it could be shown that the vaginal polymicrobial Gardnerella biofilm was temporarily suppressed during metronidazole treatment, turning into some dormant state, yet that the biofilm quickly regained its activity following treatment cessation. Although time to follow-up was too short in this study to document any clinical bacterial vaginosis recurrences, the observations on biofilm strongly suggest it to be a mechanism involved in the recurrence of bacterial vaginosis, as has been known for other recalcitrant infections involving biofilm mode of growth [15 && ]. The study was in a slightly modified setup repeated with an oral course of moxifloxacin, a quinolone agent that had not previously been assessed in the treatment of bacterial vaginosis [16] . A similar observation was made, that is, in almost half of the cases resurgence of the biofilm was observed after 10-12 weeks. We have recently evaluated lactate gel as an alternative treatment, but found that lactate also failed to eradicate the biofilm (Swidsinski et al., unpublished observation). Finally, we also studied the potential of octenidine hydrochloride in the treatment of bacterial vaginosis. Surprisingly, we found that octenidine did eradicate the polymicrobial biofilm in most patients. However, 6 months after repeated treatment with octenidine hydrochloride, recurrence rates similar to those observed with metronidazole were found (Swidsinski et al., unpublished observation).
Though no proper in-vitro model of the bacterial vaginosis film at present exists, it is worth mentioning that a recent series of experiments do suggest that probiotics may have a place as an adjuvant to antibiotic therapy in treating bacterial vaginosis as has been found in clinical studies [17] . McMillan et al. [18 && ] grew a 12-mm thick confluent A. vaginae and G. vaginalis biofilm, which they evaluated for changes occurring with antibiotic and probiotic treatment. It was found that metronidazole produced holes throughout the biofilm, however without eradicating the bacteria. Challenge with the probiotic lactobacilli L. reuteri RC-14 and L. rhamnosus GR-1, however, led to extensive bacterial death in the biofilm [18 && ]. Recent studies also reported the activity of thymol [19] and of a synthetic retrocyclin [20] against a monoculture G. vaginalis biofilm. It is questionable, however, how well an in-vitro monoculture G. vaginalis biofilm reflects the in-vivo polymicrobial bacterial vaginosis biofilm.
CONCLUSION
The discovery of bacterial vaginosis as a polymicrobial biofilm infection has certainly not simplified our understanding of this complex, anaerobic overgrowth condition. It is clear that the latter discovery has far-reaching implications for the pathogenesis, epidemiology and treatment of bacterial vaginosis. Future research may now focus on the ability of novel therapeutic agents to tear down the biofilm configuration, but is hampered by the lack of a validated in-vitro model of bacterial vaginosis.
